New combo approach may offer a better shot at controlling recurrent nose cancer
NCT ID NCT07129772
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 28 times
Summary
This study tests whether giving immunotherapy (pembrolizumab) plus chemotherapy before and after surgery can improve outcomes for people whose nasopharyngeal cancer has returned locally. About 53 adults with recurrent cancer that hasn't spread will receive the drug combo, then undergo minimally invasive surgery to remove any remaining tumor, followed by maintenance immunotherapy. The goal is to see if this approach can achieve a complete disappearance of cancer cells and possibly reduce the need for lifelong treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CANCINOMA (NPC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Clinical Oncology, Queen Mary Hospital
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.